Jeff Livingston, MD
Obstetrics & Gynecology · Irving, TXNPI 1518960764
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53,715 of the $83,296 with a category attached, or 64.5%. 15 manufacturers reported payments, led by Merck at 49.5% of the total. Reporting peaked in 2019 at $67,571 and has fallen 99.8% since, to $165 in 2024. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $599.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$41K
- Boston Scientific$30K
- Dysis Medical, Inc.$6K
- Hologic Sales And Service, LLC$5K
- Bayer$1K
- AbbVie$170
- plus $444 from 9 others
Across 194 payments — averaging $8160.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mylan Inc.$688K
- AbbVie$195K
- Abbott$189K
- Mylan Technologies Inc.$183K
- Evofem Biosciences, Inc.$99K
- Bayer$89K
- plus $140K from 4 others
What the payments were for
- Consulting fees$17,00420%
- Speaking & faculty fees$53,71564%
- Travel & lodging$10,90213%
- Food & beverage$1,6742%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 62 | $41,209 |
| Boston Scientific | 37 | $29,657 |
| Dysis Medical, Inc. | 6 | $5,800 |
| Hologic Sales And Service, LLC | 2 | $4,608 |
| Bayer | 2 | $1,408 |
| AbbVie | 10 | $170 |
| Shield Therapeutics Inc | 3 | $156 |
| Astellas Pharma US Inc | 6 | $119 |
| Coopersurgical, Inc. | 3 | $44 |
| Evofem Biosciences, Inc. | 2 | $31 |
| Avion Pharmaceuticals | 2 | $27 |
| Minerva Surgical, Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Scynexis, Inc. | 1 | $16 |
| Acessa Health Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$40,655
- SYMPHION$14,217
- GENERAL UTERINE TISSUE REMOVAL$13,146
- DYSIS v3 Digital Coploscope$8,700
- Ultra 2.0$2,900
- DYSIS Ultra$2,900
- DYSIS Ultra 2.0$2,900
- GENERAL - THERAPIES$1,834
- Kyleena$1,385
- Mirena$1,385
- ACCRUFER$106
How this compares
$83,296 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Irving
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.